Endothelin-1 Increases the Pulmonary Microvascular Pressure and Causes Pulmonary Edema in Salt Solution but not Blood-Perfused Rat Lungs

Publisher Website
Google Scholar
Abstract
Summary: Endothelin-1 (ET-1) is a potent vasoactive peptide that has been reported to cause lung edema. This study tested if the edemagenic effect of ET-1 is due to preferential venoconstriction and, if so, whether the site of resistance is similar with salt solution (PSS) and more physiologic blood perfusate. ET-1 caused concentration-dependent contraction of pulmonary arterial and venous rings, with an EC50 of 1.3 nM in artery and 0.6 nM in vein (p < 0.05). In PSS-perfused lungs, 5 nM ET-1 caused a 7.0 ± 0.8 torr pressor response that was associated with a 5.0 ± 0.3 torr increase in microvascular pressure and a 530 ± 20 mg increase in lung weight within 10 min. In contrast, KCl-treated lungs had an equivalent pressor response (7.4 ±1.1 torr), yet the microvascular pressure increased by only 2.5 ± 0.4 torr (p < 0.05 from ET-1) and the lung weight was unchanged. Meclofenamate did not prevent the effect of ET-1 on microvascular pressure or lung weight. In blood-perfused lungs, ET-1 caused a 7.3 ± 0.1 torr pressor response but only a 2.0 ± 0.5 torr increase in microvascular pressure and no increase in lung weight. ET-1 had no effect on permeability either of cultured endothelial cell monolayers or in the pulmonary microvasculature in vivo. We conclude that the edemagenic effect of ET-1 in PSS-perfused lungs is mediated through venoconstriction and an increase in microvascular pressure. The physiological significance of this increase is uncertain, as blood perfusate appears to shift the principal site of vasoconstriction from post- to precapillary vessels, thus preventing the increase in microvascular pressure and edema.

This publication has 2 references indexed in Scilit: